Form 4: Elanco Animal Health Executive James M. Meer Reports Stock Transactions

James M. Meer, Chief Accounting Officer of Elanco Animal Health Inc., reports acquisition of 2,483 shares and disposal of 854 shares of common stock on February 27, 2024.

Summary

• On February 27, 2024, James M. Meer, the Chief Accounting Officer of Elanco Animal Health Inc., acquired 2,483 shares of common stock.
• On the same day, Meer disposed of 854 shares of common stock at a price of $16.46.
• Following these transactions, Meer beneficially owns 42,968 shares of Elanco Animal Health Inc.
• The transactions were reported on a Form 4 filing with the SEC on February 29, 2024.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions, with no inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by SEC regulations. It provides transparency into the trading activities of key personnel and their alignment with shareholder interests.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency regarding insider transactions.
• Similar filings are made by executives at companies like Zoetis and Merck Animal Health, providing insights into their stock ownership and trading activities.

Stakeholder Impact

• The transactions may have a minor impact on shareholder sentiment, depending on how investors interpret insider trading activity.
• The transactions are unlikely to have a significant impact on employees, customers, suppliers, or creditors.

Key Dates